ETAO International (ETAO) Stock Analysis
NASDAQHealthcareMedical - Healthcare Information Services
What ETAO International does
ETAO International Co., Ltd., headquartered in New York, is a digital healthcare firm specializing in providing medical services and advanced biomedical technologies to patients throughout China. The company is actively constructing an expansive healthcare ecosystem. This comprehensive network is designed to integrate hospitals, specialized clinics, artificial intelligence and big data-powered diagnostic tools, medical analysis services, biotechnology companies, and an insurance agency, all aimed at ensuring patients have seamless access to medical assistance and a broad spectrum of healthcare services.
Key metrics
ETFs linked to ETAO
Broad-market and Healthcare sector ETFs an investor holding ETAO International is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ETAO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ETAO in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for ETAO International?
- ETAO International trades under the ticker ETAO on NASDAQ.
- Which exchange is ETAO listed on?
- ETAO is listed on NASDAQ.
- What sector does ETAO International operate in?
- ETAO International is classified in the Healthcare sector (Medical - Healthcare Information Services industry).
- How can PortView help analyze ETAO in a portfolio?
- PortView shows ETAO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.